TGFB1 and neoplasm: Knowledge of the role of TGF-β in tumour immune evasion comes largely from studies using animal models where disruption of TGF-β signalling, either by genetic means or using inhibitory agents, can restore anti-tumour immunity, identifying this evasion pathway as a promising therapeutic target [14], [20], [34].